Ovarian cancer treatment in Istanbul, Turkey
Ovarian cancer is usually treated with a combination of debulking surgery and platinum-based chemotherapy, with PARP-inhibitor maintenance for many patients whose tumours carry a BRCA mutation or HRD. Istanbul hospitals offer this full pathway, often at JCI-accredited, state-authorized centers and well below Western-European prices for the same protocol. Every price we show is an illustrative placeholder until verified partner-hospital quotes exist — and you pay the hospital directly, never us. Start with a free 72-hour review of your reports before you decide anything.
Organs of the female reproductive system — the uterus, ovaries, fallopian tubes, cervix and vagina.
SEER Training Modules, U.S. National Cancer Institute — public domain (opens in a new tab) ↗What ovarian cancer is
The U.S. National Cancer Institute groups ovarian, fallopian tube and primary peritoneal cancer together because they behave and are treated in much the same way. Most cases are epithelial — high-grade serous carcinoma is the most common — while germ-cell and stromal tumours are rarer and tend to occur in younger women. Because early symptoms (bloating, pelvic or abdominal pain, feeling full quickly, urinary urgency) are vague and there is no reliable screening test for average-risk women, the NCI notes it is often diagnosed at an advanced stage.
Diagnosis typically involves a pelvic exam, transvaginal ultrasound, a CA-125 blood test and CT imaging, with surgery and pathology giving the definitive answer and the FIGO stage. BRCA1/BRCA2 and HRD testing increasingly guide both treatment and family risk. Browse the wider cancer types hub for related diagnoses.
Treatment options
The modalities the NCI lists for ovarian cancer, and an honest note on each:
- Debulking (cytoreductive) surgery. The cornerstone — the surgeon removes as much visible tumour as possible, often with hysterectomy, removal of both ovaries and tubes, and omentectomy. How completely disease can be removed is one of the strongest influences on outcome.
- Chemotherapy. Platinum-based regimens (commonly carboplatin with paclitaxel), given after surgery or, in some cases, before it (neoadjuvant) to shrink disease first. Cost scales with the number of cycles.
- PARP inhibitors (maintenance). Drugs such as olaparib or niraparib used as maintenance, especially for BRCA-mutated or HRD-positive tumours. They are priced per month, so a maintenance course can be a large part of the total cost.
- Targeted / anti-angiogenic therapy. Bevacizumab may be added in some plans. Stromal tumours can sometimes be treated with hormone therapy. Which of these applies is decided by your pathology, not a template.
See how these modalities work in general on the treatments & technology hub.
What it costs
There is no single ovarian-cancer price, because the cost is driven by the extent of debulking surgery, the number of chemotherapy cycles, and whether PARP-inhibitor maintenanceis used — those maintenance drugs are billed per month and can outweigh the surgery itself. Every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, and each is itemized so you can hold a real quote up against it line by line. See the Turkey Oncology Price Index or the full cancer treatment cost in Turkey breakdown.
The hospital, verified
We don’t show a wall of smiling surgeons or a “ranked” list — those are the easiest things to fabricate. Instead, you’re matched to one state-authorized Istanbul partner hospital whose gynecologic-oncology subspecialty fits your diagnosis, and you can verify its authorization against the Republic of Turkey Ministry of Health’s own records and its JCI accreditation in JCI’s public directory before you commit. Named specialist profiles appear only when a verified, consented physician is behind the name. See the full guide to cancer hospitals in Istanbul and how to check one yourself.
Where this fits
This is one diagnosis within the broader cancer treatment in Istanbul pillar. If you want your own reports read first, a free second opinion organizes and verifies your pathology and imaging into a plain-language case file in your language before you decide whether to travel.
Related cancers
You might also look at
Check everything here — us included
Common questions
Can I get ovarian cancer treatment in Turkey?
Yes. Istanbul hospitals provide the full ovarian-cancer pathway the U.S. National Cancer Institute describes — cytoreductive (debulking) surgery, platinum-based chemotherapy such as carboplatin with paclitaxel, BRCA and homologous-recombination testing, and PARP-inhibitor or anti-angiogenic maintenance where indicated. Many hold JCI accreditation and Turkish Ministry of Health state authorization, both of which you can check yourself before you commit. The honest first step is a free case review of your pathology and imaging so the plan is understood before you travel.
How much does ovarian cancer treatment cost in Istanbul?
It depends on stage, how extensive the debulking surgery is, the number of chemotherapy cycles, and whether maintenance therapy such as a PARP inhibitor is used — those maintenance drugs are priced per month and can dominate the total. Istanbul typically runs well below Western-European prices for the same protocol, but every figure OncologyIstanbul™ publishes today is an illustrative placeholder pending verified partner-hospital quotes, itemized so you can check a real written quote line by line. See the Turkey Oncology Price Index for current ranges.
What is the success rate for ovarian cancer treatment?
There is no single honest number, and we will not sell you one. Outcomes are individual and are driven by the stage at diagnosis, the tumour type (most cases are epithelial high-grade serous), how completely the surgeon can remove visible disease, and BRCA/HRD status — not by which country you choose. The NCI notes ovarian cancer is often found at an advanced stage because early symptoms are vague, which is exactly why the treatment plan matters more than any marketing statistic. Ask your oncologist what your specific stage and pathology mean for you.
Do I need BRCA or genetic testing for ovarian cancer?
Genetic and tumour testing has become a standard part of the workup. Per the NCI, BRCA1/BRCA2 mutations and homologous-recombination-deficiency (HRD) status help decide whether PARP-inhibitor maintenance is likely to help, and also carry information for your family's risk. Istanbul hospitals can run this testing, and a case review will flag whether it has already been done on your reports. This is general information — whether and when to test is a decision for your treating team.
Start with a free 72-hour case review
Send your pathology and imaging. Get a verified case file in your language — free, confidential, no obligation.
This page is general information, not medical advice. Medical facts are grounded in the U.S. National Cancer Institute; prices shown are illustrative placeholders pending verified partner-hospital quotes, not offers. Every cancer case is individual; assessments are based on the reports you provide and do not replace in-person examination.